Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dezocine |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Pentazocine lactate (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Pentazocine hydrochloride |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Phenazocine hydrobromide |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Qualitative measurement of opiate agonist |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Alfentanil measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Alphaprodine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Anileridine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Codeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dextromoramide measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Diamorphine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Mersalyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Oxycodone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Methylfentanyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Norfentanyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
6-beta-Naltrexol measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
6-Monoacetylmorphine measurement (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Moricizine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Oxymorphone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Paramethadione measurement (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Despropionylfentanyl measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Methadone, long acting metabolite measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Oxycodeinone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Opioid screening |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Methadone measurement, urine |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Urine morphine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Methadone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Urine codeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Urine opiate measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Serum morphine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 400 microgram/1 each conventional release sublingual tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine (as buprenorphine hydrochloride) 2 mg sublingual tablet |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 8 milligram/1 each conventional release sublingual tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine (as buprenorphine hydrochloride) 200 microgram sublingual tablet |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
buprenorfin 300 mikrogram/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
pentazocin 30 mg/ml, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
pentazocin 30 mg/ml, injektionsvätska, lösning, ampull 2 ml |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Pentazocine (as pentazocine lactate) 50 mg rectal suppository |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
bensomorfanopioid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dimethadione measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Opiate agonist-antagonist product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Butorphanol product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing precisely butorphanol tartrate 10 milligram/1 milliliter conventional release nasal spray (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Nalbuphine product |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
butorfanoltartrat 2 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
butorfanoltartrat 1 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
nalbufinhydroklorid 20 mg/ml, injektionsvätska, lösning, ampull |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dextropropoxyphene (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dihydrocodeine (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Phenazocine (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dextromoramide (substance) |
Is a |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Serum methadone level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Urine diamorphine level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Oral fluid opiate level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Oral fluid morphine level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Oral fluid methadone level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Urine methadone metabolite level (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing pentazocine (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Meperidine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dihydromorphinone measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Opiates |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Trimethadione measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Quantitative measurement of opiate agonist |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Nalorphine measurement (procedure) |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
mätning av dihydrokodeinon |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Morphine measurement, quantitative |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
screening och mätning av morfin |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing butorphanol (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing buprenorphine (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing nalbuphine (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Nalbuphine hydrochloride [central nervous system use] |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Nalbuphine hydrochloride [anesthesia] |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine 70micrograms/hour transdermal patch |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine 52.5micrograms/hour transdermal patch |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine 35micrograms/hour transdermal patch |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Buprenorphine hydrochloride + naloxone hydrochloride |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
buprenorfin 35 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
buprenorfin 52,5 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
buprenorfin 70 mikrogram per timme, depåplåster |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Pentazocine hydrochloride 25 mg oral tablet |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
nalbufinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
paracetamol 650 mg + pentazocinhydroklorid 25 mg, kapseltablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
acetylsalicylsyra + pentazocinhydroklorid 325 mg, tablett |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
paracetamol + pentazocinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
naloxonhydroklorid + pentazocinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
acetylsalicylsyra + pentazocinhydroklorid |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Dihydrocodeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Urine dihydrocodeine measurement |
Component |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|
Product containing buprenorphine and naloxone (medicinal product) |
Has active ingredient |
False |
Opiate agonist-antagonist |
Inferred relationship |
Some |
|